Diabetes Drug | featured news

FDA questions safety of experimental diabetes drug

Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers ...


Wal-Mart hikes branded diabetes drug prices-study

Big-box retailers Wal-Mart Stores and Kmart, pioneers in the push to cut consumer prices for generic drugs, have been raising prices for the most popular brand-name diabetes drugs, according to a new study.


For diabetes drug Avandia, bad news continues

Two new studies link the drug to increased heart risks just weeks before the FDA will consider whether it should remain on the market.

The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke.


Subscribe to this RSS topic: Syndicate content